Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.


CSE:SONA - Post by User

Bullboard Posts
Comment by TheeRookon Aug 15, 2020 11:22am
244 Views
Post# 31412539

RE:MRI Global

RE:MRI GlobalNo one is disputing the MRI Validated results for SONA.   From those results,   further studies were needed, In which the deadline was missed and a two week  extension added    Looks like another extension is coming.   SONA is too small a company to do all the work themselves and has to contract the work out or seek other third parties for assistance.   


""Following consultation with MRIGlobal and the Food and Drug Administration, Sona will enter into independent clinical, in-field evaluation studies to generate the data to support its analytical and clinical data as part of the submission it will make to Health Canada and the FDA for emergency-use authorization (EUA) approval.""


SONA   got a PPA  -  96 %  and an NPA of 96%    LOD 210

""Validation studies were also conducted in house to assess potential clinical performance of the test using 30 nasopharyngeal samples from healthy individuals who were presumed negative for COVID-19. Results from the study generated a specificity of 96 per cent (29/30) and a sensitivity of 96 per cent (28/29). All specimen samples tested generated negative results, except for one, generating the result of 96 per cent. To generate the sensitivity data, the remnants of each negative sample were spiked with gamma-irradiated COVID-19 virus and the tests rerun to determine the positive results, generating the result of 96 per cent.""


 Critical Thinking and comprehension is required here and an understanding of molecular bioscience
The FDA  wants the AntiGen Sympomatic Test to be close to full proof at catching all Symptomatic Covid patients.  Hence the HIgh Performance bar for the PPA.

SONA could have save alot of time if they just followed FDA protocols with early data  and used an FDA Approved  MD  and the  authorized ThermoFisher Scientific TaqPath test.


NothinButTime wrote:

MRI Global

 

For decades, MRIGlobal expertise has led biosafety and biorisk management program development in the U.S. and internationally.

 

“MRIGlobal offers government and commercial clients services that include assay design and clinical development through regulatory submission. We provide extensive research and product development expertise; facilities, analytical services, clinical trial site, and clinical trial services and support; and regulatory guidance to support FDA submission filings.”

 

 

This is who validated Sona’s test.  A top notch lab trusted by the US Military and the Pentagon.  A lab that helped fight the Ebola crisis, has extensive experience in obtaining FDA approvals, and received a grant from Bill Gates.  

 

Who do you trust?  These fine scientists who have top notch expertise in testing devices and biological threats, or some random guys who say the company has nothing.  

 

As David said, “we have an antigen test that works, which is an extraordinary thing”.  

 

My money is on the guys that keep their heads down and get to work.  Less talking, more proving.  Show and prove.  That’s all this company has done.



Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse